MAO GEPING (01318): The China Securities Regulatory Commission has issued a filing notice for the full circulation of the company's H shares.

21:24 16/01/2026

China Ming Gong (01318) announced that the company has recently received a filing notice from the China Securities Regulatory Commission regarding the implementation of full circulation of H shares, dated January 13, 2026 (the filing notice). According to the filing notice, the company has completed the filing with the China Securities Regulatory Commission for the full circulation of a total of 228 million unlisted shares. The filing notice is valid for 12 months from January 13, 2026. The company will apply to the Listing Committee of the Stock Exchange for approval of the listing and trading of the relevant H shares.

MAO GEPING (01318) announced that the company has recently received a record notice from the China Securities Regulatory Commission regarding the implementation of full circulation of H shares, dated January 13, 2026. According to the record notice, the company has completed the record for the implementation of full circulation of 228 million unlisted shares to the China Securities Regulatory Commission. The record notice is valid for 12 months from January 13, 2026. The company will apply to the Listing Committee of the Stock Exchange for approval of the listing and trading of relevant H shares.

Haisco Pharmaceutical Group (002653.SZ): Innovative drug HSK31679 tablet included in breakthrough therapy program.

Yinbang Clad Material (300337.SZ) is planning to register and issue medium-term notes.

HK Stock Market Move | NATURAL FOOD IH(01837) continues to rise by over 5%, offline channel business significantly grows, with annual net profit increasing by approximately 40% compared to the previous year.

Haisco Pharmaceutical Group (002653.SZ): Innovative drug HSK31679 tablet included in breakthrough therapy program.

Yinbang Clad Material (300337.SZ) is planning to register and issue medium-term notes.